• Explore /
  • Poster
  • / Long-term follow up for a phase I trial HER2/neu-targeted T cells in women with advanced breast cancer.

Long-term follow up for a phase I trial HER2/neu-targeted T cells in women with advanced breast cancer.

Abstract Poster

Authors

null

Lawrence G. Lum

Karmanos Cancer Institute, Wayne State University, Detroit, MI

Lawrence G. Lum , Archana Thakur , Zaid S. Al-Kadhimi , Gerald A. Colvin , Francis J. Cummings , Robert Duffy Legare , Don S. Dizon , Nicola Kouttab , Abby Maizel , William Colaiace , Qin Liu , Ritesh Rathore

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT00027807

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 3075)

DOI

10.1200/jco.2014.32.15_suppl.3075

Abstract #

3075

Poster Bd #

142

Abstract Disclosures

Similar Posters

First Author: Lawrence G. Lum

First Author: Deepa Bai Jagtap

First Author: Rongsu Qi

First Author: Yuankai Shi